AIM
CRL icon

Anchor Investment Management’s Charles River Laboratories CRL Stock Holding History

Anchor Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5K Hold
29
– – ﹤0.01% 898
2025
Q4 		$5.79K Hold
29
– – ﹤0.01% 883
2025
Q3 		$4.54K Sell
29
-2
-6% -$318 ﹤0.01% 915
2025
Q2 		$4.7K Hold
31
– – ﹤0.01% 895
2025
Q1 		$4.67K Hold
31
– – ﹤0.01% 890
2024
Q4 		$5.72K Hold
31
– – ﹤0.01% 865
2024
Q3 		$6.11K Hold
31
– – ﹤0.01% 857
2024
Q2 		$6.4K Hold
31
– – ﹤0.01% 813
2024
Q1 		$8.4K Buy
+31
New +$7.4K ﹤0.01% 808

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Anchor Investment Management's CRL Position: Q1 2026 in Review

Anchor Investment Management held its Charles River Laboratories (CRL) position steady in Q1 2026 at 29 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #898.

Anchor Investment Management first reported a position in CRL in Q1 2024 and has held it in 9 quarters since. The position peaked at $8.4K in Q1 2024. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Anchor Investment Management held 29 shares of Charles River Laboratories worth $5K as of Q1 2026.
  • Anchor Investment Management left its Charles River Laboratories share count unchanged in Q1 2026.
  • Charles River Laboratories made up ﹤0.01% of Anchor Investment Management's portfolio in Q1 2026, its #898 holding.
  • Anchor Investment Management first reported a position in Charles River Laboratories in Q1 2024 and has held it in 9 quarters since.
  • Anchor Investment Management's Charles River Laboratories position peaked at $8.4K in Q1 2024.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.